
McKesson ( MCK -1.7% ) slips on a likely bout of profit-taking after its FQ4 earnings easily beat estimates late yesterday. Net profit
McKesson 's MCK fiscal 2012 fourth-quarter results ..... view the stock as about fairly valued. McKesson 's full-year adjusted earnings per ..... contract removed a significant overhang on McKesson 's revenue outlook. The distribution
April 30 (Reuters) - Pharmaceutical wholesaler McKesson Corp on Monday reported a higher quarterly profit on a 10 percent rise in sales from its core drugs distribution business, and it issued an earnings forecast for fiscal 2013 in line with Wall Street estimates.
April 30 (Reuters) - Pharmaceutical wholesaler McKesson Corp on Monday reported a higher quarterly profit on a 10 percent rise in sales from its core drugs distribution business, and it issued an earnings forecast for fiscal 2013 largely in line with Wall Street estimates.
McKesson ( MCK ): FQ4 EPS of $2.09 beats by $0.05 . Revenue of $31.7B (+9.9% Y/Y) beats by $1.4B . ( PR ) Post your comment!
Good afternoon, and welcome to the McKesson Corporation Fourth Quarter Fiscal ..... Good afternoon and welcome to the McKesson fiscal 2012 fourth quarter earnings ..... With me today are John Hammergren, McKesson 's Chairman and CEO; and Jeff Campbell
McKesson ( MCK ) will pay $190M to settle government allegations that the drug distribution giant improperly inflated drug prices that led to
April 26 (Reuters) - McKesson Corp , one of top U.S. drug wholesalers, has agreed to pay more than $190 million to settle claims that it had violated the federal False Claims Act by reporting inflated...
April 26 (Reuters) - McKesson Corp , one of top U.S. drug wholesalers, has agreed to pay more than $190 million to settle claims that it had violated the federal
April 26 (Reuters) - McKesson Corp , a large U.S. drug wholesaler, has agreed to pay more than $190 million to settle claims that it violated the federal False Claims Act by reporting inflated pricing...